Trial Profile
A phase I, double-blinded, placebo-controlled therapeutical vaccine trial to evaluate the immunogenicity and VL Rebound After ATI in Chronic HIV Infected Patients Receiving MVA-B
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs HIV vaccine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Dec 2015 New trial record